Pôle Pharmacie, Unité D'Expertise Pharmaceutique Et Recherche Biomédicale, Aix Marseille Univ, APHM, Hôpital de La Timone, Marseille, France.
Service de Médecine Interne, Gériatrie Et Thérapeutique, Aix Marseille Univ, APHM, Hôpital de La Timone, Marseille, France.
Int J Clin Pharm. 2021 Oct;43(5):1183-1190. doi: 10.1007/s11096-021-01229-y. Epub 2021 Jan 19.
Background Medication reconciliation prevents medication errors at care transition points. This process improves communication with general practitioners regarding the reasons for therapeutic changes, allowing those changes to be maintained after hospital discharge. Objective To investigate the impact of medication reconciliation in geriatrics on the sustainability of therapeutic optimization after hospital discharge. Setting This study was conducted in a geriatric unit in a University Hospital Centre in France. Method This was a retrospective study. For 6 months, all patients over 65 years who underwent the process of medication reconciliation performed by a clinical hospital pharmacist and a physician at admission and discharge, were included. A comparison between drug prescriptions at hospital discharge and the first prescription made outside the hospital was made to identify any differences. Main outcome measure The main outcome measures were the provision of the results of the medication reconciliation performed in the hospital to the relevant general practitioner, the subsequent acceptance of that information, the type of medication discrepancies one month after discharge and the therapeutic classes affected by the modifications. Results Among the 112 patients, medication reconciliation allowed us to identify and correct 87 unintentional discrepancies at admission (88% corrected) and 54 at discharge (92% corrected). Patients were discharged to homes or nursing homes (61%), geriatric rehabilitation units (38%) or psychiatric clinics (1%). A general practitioner wrote the first prescription renewal a mean of 36 ± 23 days after discharge, having been made aware of the medication reconciliation in only 24% of the cases (received and taken into account). The impact was a decrease in the number of patients with at least one discrepancy. Twenty-five percent of general practitioners who were aware about the medication reconciliation process accepted all therapeutic changes, while only 7% of those who were not informed did so (p = 0.02). The number of medication discrepancies observed was correlated with the number of medications for which prescriptions were renewed (p < 0.01). Conclusion Medication reconciliation involving therapeutic optimization and the justification of changes is essential to ensure the safety of the prescriptions written for patients. However, its impact after discharge is hampered by the fact that the results are often not received or taken into account by general practitioners. Taking medication reconciliation into account was associated with a significant increase in prescriptions that maintained therapeutic changes made in the hospital, confirming the positive impact of communication between care providers on therapeutic optimization.
药物重整可预防医疗过渡点的用药错误。该过程改善了与全科医生的沟通,了解治疗改变的原因,从而在出院后维持这些改变。目的:研究老年医学中药物重整对出院后治疗优化可持续性的影响。地点:该研究在法国一所大学医院中心的老年科进行。方法:这是一项回顾性研究。在 6 个月的时间里,所有接受过临床医院药剂师和医生在入院和出院时进行的药物重整的 65 岁以上患者均被纳入研究。比较出院时的药物处方与出院后首次处方,以确定差异。主要结果:主要结果是向相关全科医生提供在医院进行的药物重整结果,随后全科医生接受这些信息,出院后一个月的药物差异类型和受修改影响的治疗类别。结果:在 112 名患者中,药物重整可识别并纠正入院时的 87 例非故意差异(纠正率为 88%)和出院时的 54 例差异(纠正率为 92%)。患者出院后返回家庭或疗养院(61%)、老年康复病房(38%)或精神病诊所(1%)。全科医生平均在出院后 36±23 天开出第一张处方续方,只有 24%的情况下了解药物重整(收到并考虑在内)。结果是减少了至少有一处差异的患者人数。25%的了解药物重整过程的全科医生接受了所有的治疗改变,而没有收到通知的全科医生中只有 7%的人接受了治疗改变(p=0.02)。观察到的药物差异数量与需要续方的药物数量相关(p<0.01)。结论:涉及治疗优化和改变理由的药物重整对于确保患者处方的安全性至关重要。然而,出院后其影响受到限制,因为全科医生通常没有收到或考虑药物重整的结果。考虑到药物重整与显著增加维持医院治疗改变的处方有关,这证实了医疗服务提供者之间的沟通对治疗优化的积极影响。